Seritage Growth Properties: Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025. Seritage Growth Properties (SRG) is a taxable C Corporation (since January 1, 2022) executing a shareholder-approved "Plan of Sale" to liquidate its portfolio of retail and mixed-use properties. As of March 31, 2025, the portfolio consisted of 16 properties (9 consolidated, 7 unconsolidated) totaling approximately 1.6 million square feet of gross leasable area and 240 acres of land. The company is actively selling assets to fund obligations and distribute proceeds to shareholders.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Total Revenue | $4.6 million | $5.8 million |
| Net Loss | $(22.2) million | $(19.0) million |
| Net Loss Attributable to Common Shareholders | $(23.4) million | $(20.2) million |
| Loss Per Share (Basic & Diluted) | $(0.42) | $(0.36) |
| Net Cash Used in Operating Activities | $(9.2) million | $(16.6) million |
| Net Cash Provided by Investing Activities | $19.8 million | $28.9 million |
| Total Assets | $649.7 million | $677.8 million |
| Cash and Cash Equivalents | $94.3 million | $85.2 million |
| Term Loan Facility Outstanding | $240.0 million | $240.0 million |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased by $1.2 million (21%) primarily due to the sale of income-producing properties in 2024, partially offset by increased rental income from the Aventura, FL property.
- Increased G&A Expenses: General and administrative expenses rose by $6.5 million to $15.7 million, driven largely by the recognition of severance expenses.
- Gain on Sale: The company recorded a $6.9 million gain on the sale of one consolidated property (gross proceeds of $29.6 million), compared to a $1.1 million gain on five properties sold in Q1 2024.
- Unconsolidated Entity Losses: Equity in loss of unconsolidated entities increased significantly to a loss of $7.9 million (from income of $0.4 million in Q1 2024), driven by an $8.5 million other-than-temporary impairment charge on investments in unconsolidated entities.
- Interest Expense Reduction: Interest expense decreased by $1.8 million to $5.2 million due to principal paydowns on the Term Loan Facility during 2024.
Outlook, Risks, and Management Commentary
- Liquidity and Going Concern: Management concluded that substantial doubt about the company's ability to continue as a going concern has been alleviated. This is based on the option to extend the Term Loan Facility maturity to July 31, 2026 (subject to a 2% fee), existing cash on hand, and expected proceeds from asset sales.
- Debt Maturity: The Term Loan Facility matures on July 31, 2025. The company has an option to extend this by one year. The company is not currently in compliance with certain financial metrics (e.g., fixed charge coverage ratios), which limits asset dispositions without lender consent, though consent has been granted for submitted transactions.
- Strategic Plan: The "Plan of Sale" remains the primary strategy. The company continues to position remaining assets for sale, though challenging market conditions (elevated interest rates, supply chain issues) may impact sale proceeds and timing.
- Legal Proceedings: The company is facing a class action lawsuit (filed July 2024) and multiple derivative lawsuits (filed Jan-May 2025) alleging violations of securities laws and breach of fiduciary duty regarding internal controls and asset valuations. The company intends to vigorously defend these actions.
- Dividends: No dividends were declared on Class A common shares. Preferred dividends of $0.4375 per share were declared and paid.
Investor Verification Checklist
- Debt Extension Feasibility: Verify the company's ability and intent to pay the 2% extension fee ($4.8 million) to extend the $240 million Term Loan Facility maturity to July 2026.
- Asset Sale Pipeline: Confirm the status of the one consolidated asset under contract for sale (anticipated proceeds of $14.0 million) and the timeline for closing.
- Impairment Risks: Monitor the $8.5 million impairment charge on unconsolidated entities and assess the risk of further impairments given the company's evaluation of holding periods and market conditions.
- Legal Exposure: Track the progress of the securities class action and derivative lawsuits, as outcomes could result in significant damages or governance changes.
- Covenant Compliance: Review the specific financial metrics (fixed charge coverage, leverage ratios) the company is currently non-compliant with and the impact on future asset sales.